Shandong Weigao boosts treasury, repurchases continue

On September 1, 2025, Shandong Weigao Group Medical Polymer Company Limited repurchased 380,000 H shares on the Exchange. The average repurchase price for these shares was HK$5.8395, with the highest price being HK$5.86 and the lowest HK$5.8. The total price paid for this buyback amounted to HK$2,219,000. These repurchased shares will be held as treasury shares.

Following this transaction, the company's number of issued shares (excluding treasury shares) decreased from 4,511,363,924 to 4,510,983,924, representing a 0.0084% change. Concurrently, the number of treasury shares increased from 10,968,400 to 11,348,400. The total number of issued shares remains at 4,522,332,324.

The repurchase was executed under a mandate granted on May 27, 2025, which authorized the company to repurchase up to 451,560,392 shares. To date, 4,700,000 shares have been repurchased under this mandate, representing 1.0408% of the issued shares (excluding treasury shares) at the date of the resolution. A moratorium period for new share issues or sales of treasury shares after this repurchase extends until October 1, 2025.